GX Pharma logo — A leader in innovative drug research and clinical solutions,...

GX Pharma

A leader in innovative drug research and clinical solutions, recognized among China's top outsourcing firms in pharmaceuticals for three consecutive years.

Founded 2008 Series B Total: $290.00M Biotechnology

General Information

Company Name GX Pharma
Founded Year 2008
Industries Biotechnology
Funding Stage Series B
Social

Get notified when GX Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GX Pharma

GX Pharma, a leader in innovative drug research and clinical solutions, has been recognized among China's top outsourcing firms in pharmaceuticals for three consecutive years. Founded in 2008, the company specializes in pioneering drug research and development, as well as clinical trials. GX Pharma offers comprehensive clinical research services and provides complete registration and declaration solutions for innovative drugs and biological products. Since 2018, GX Pharma has consistently been acknowledged as one of the "Top 20 Outsourcing Companies in China's Pharmaceutical Industry" for three consecutive years. The company's most recent investment was a CNY90.00M Series B investment on 13 December 2022, with participation from In Capital, Zhongguancun Bank, and Shenzhen Qianhai Beizeng Asset Management. GX Pharma's focus on cutting-edge drug research, strong track record of recognition, and recent significant investment make it a compelling player in the biotechnology industry, with promising growth potential and a solid foundation for further expansion and innovation.

Taxonomy: drug research, clinical solutions, CRO, pharmaceutical outsourcing, clinical trials, registration solutions, biological products, innovative drugs, China pharmaceutical industry, new drug development, top outsourcing companies, clinical research services

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 3
Investor
•••• ••••
13 Dec 2022
Series B •••••• 2
Investor
•••• ••••
27 Oct 2021
Series A •••••• 1
Investor
24 Sep 2020

GX Pharma Alternatives & Competitors

GX Pharma vs

Delivering Excellence in Drug Research and Development with Industry-Leading Expertise

Series B
Biotechnology, Health Care
GX Pharma vs

Premier clinical research site in Mississippi founded in 2004 by Dr. Joseph Kwentus.

7 employees
Health Care, Health and Wellness
GX Pharma vs

Easy, we make it

2 employees

FAQ About GX Pharma

A leader in innovative drug research and clinical solutions, recognized among China's top outsourcing firms in pharmaceuticals for three consecutive years.
GX Pharma was founded in 2008.
GX Pharma operates in the following industries: Biotechnology.
GX Pharma has completed 3 funding rounds, raising a total of $290.00M. The latest funding stage is Series B.
Top alternatives and competitors to GX Pharma include BociMed, Precise Research Centers, Apron Biotechnology, Coiled, LSK Global PS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GX Pharma and BociMed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GX Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes